Deliver Your News to the World

CybeRelease: (OTC BB: IVME) New To OTCReporter.com


WEBWIRE

(CybeRelease, August 3, 2006) - Lake Harmony – OTCReporter.com starts coverage of In Veritas Medical Diagnostics Inc. (OTC BB: IVME).

About the Company:

In Veritas Medical Diagnostics uses it’s proven, patented core technology to design, develop and test medical devices for near patient testing and monitoring. In Veritas Medical Diagnostics’ products serve large global markets in the monitoring of chronic conditions affecting large numbers of the population. Two applications form the focus of current development work. The first is a device for measuring the coagulation of blood in patients with cardiovascular disorders, which is in the last stages of clinical trials. The second is a device that predicts the onset of human labor up to several weeks before birth. For more information about In Veritas Medical Diagnostics, please visit its website at http://www.ivmd.com.

For a Free Newsletter and more information, go to http://www.OTCReporter.com.

CybeRelease Gainers are MRO Software, Inc. (Nasdaq: MROI), Cryptologic, Inc. (Nasdaq: CRYP), Sina Corporation (Nasdaq: SINA), FoxHollow Technologies, Inc. (Nasdaq: FOXH), bebe stores, Inc. (Nasdaq: BEBE), Jos. A. Bank Clothiers, Inc. (Nasdaq: JOSB), SunOpta, Inc. (Nasdaq: STKL) and Global Industries, Ltd. (Nasdaq: GLBL).

CybeRelease Decliners are Cogent, Inc. (Nasdaq: COGT), Eclipsys Corporation (Nasdaq: ECLP), Starbucks Corporation (Nasdaq: SBUX), TOP Tankers Inc. (Nasdaq: TOPT), CompuCredit Corporation (Nasdaq: CCRT), Gymboree Corporation (The) (Nasdaq: GYMB), Extreme Networks, Inc. (Nasdaq: EXTR) and Lawson Software, Inc. (Nasdaq: LWSN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.





WebWireID17875





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.